BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$140M |
| 2 |
iShares US Financials ETF
IYF
|
+$119M |
| 3 |
AGN
Allergan plc
AGN
|
+$100M |
| 4 |
Charter Communications
CHTR
|
+$95.1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$82.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$909M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.73% |
| 2 | Financials | 5.47% |
| 3 | Healthcare | 4.96% |
| 4 | Consumer Discretionary | 4.64% |
| 5 | Industrials | 3.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
NACCO Industries
NC
$317M
| $42.6K | ﹤0.01% |
909
+306
| +51% | +$16.2K |
|
3602
KVH Industries
KVHI
$142M
| $42.4K | ﹤0.01% |
3,810
+1,143
| +43% | +$12.1K |
|
|
MTEM
3603
DELISTED
Molecular Templates, Inc.
MTEM
| $42.4K | ﹤0.01% |
202
+53
| +36% | +$7.62K |
|
3604
Nathan's Famous
NATH
$397M
| $42.2K | ﹤0.01% |
596
+131
| +28% | +$9.65K |
|
3605
Transmedics
TMDX
$3.02B
| $42.2K | ﹤0.01% |
2,222
+1,388
| +166% | +$25.5K |
|
3606
IES Holdings
IESC
$15.3B
| $42.2K | ﹤0.01% |
1,645
+278
| +20% | +$6.01K |
|
3607
Nomad Foods
NOMD
$1.59B
| $41.9K | ﹤0.01% |
1,875
+623
| +50% | +$12.7K |
|
3608
Northeast Bank
NBN
$1.15B
| $41.8K | ﹤0.01% |
1,901
+662
| +53% | +$14.6K |
|
|
ACOR
3609
DELISTED
Acorda Therapeutics
ACOR
| $41.7K | ﹤0.01% |
171
+103
| +151% | +$26K |
|
3610
Riverview Bancorp
RVSB
$106M
| $41.7K | ﹤0.01% |
5,077
+1,590
| +46% | +$11.9K |
|
3611
Ardelyx
ARDX
$1.03B
| $41.5K | ﹤0.01% |
5,536
-1,602
| -22% | -$9.73K |
|
3612
ProShares Short Real Estate
REK
$11.9M
| $41.5K | ﹤0.01% |
+1,613
| New | +$42.1K |
|
3613
PUT
McKesson
MCK
$102B
| $41.5K | ﹤0.01% |
3
| – | – |
|
3614
Merchants Bancorp
MBIN
$2.52B
| $41.5K | ﹤0.01% |
3,158
+674
| +27% | +$7.86K |
|
3615
Verrica Pharmaceuticals
VRCA
$87.4M
| $41.4K | ﹤0.01% |
261
+75
| +40% | +$11.1K |
|
3616
Rigel Pharmaceuticals
RIGL
$782M
| $41.4K | ﹤0.01% |
1,933
-742
| -28% | -$15.3K |
|
3617
Cue Biopharma
CUE
$128M
| $41.3K | ﹤0.01% |
87
-11
| -11% | -$3.46K |
|
|
GPX
3618
DELISTED
GP Strategies Corp.
GPX
| $41.2K | ﹤0.01% |
3,112
+1,087
| +54% | +$13.5K |
|
|
ORBC
3619
DELISTED
ORBCOMM, Inc.
ORBC
| $41.2K | ﹤0.01% |
9,778
-1,908
| -16% | -$8.15K |
|
3620
Alphatec Holdings
ATEC
$1.49B
| $41.1K | ﹤0.01% |
5,797
+2,026
| +54% | +$13K |
|
3621
XBiotech
XBIT
$75M
| $41.1K | ﹤0.01% |
2,202
+1,333
| +153% | +$17.2K |
|
3622
MasterCraft Boat Holdings
MCFT
$600M
| $41K | ﹤0.01% |
2,600
-334
| -11% | -$5.27K |
|
|
MR
3623
DELISTED
Montage Resources Corporation Common Stock
MR
| $40.8K | ﹤0.01% |
5,139
+3,407
| +197% | +$17.8K |
|
3624
Crinetics Pharmaceuticals
CRNX
$8.96B
| $40.7K | ﹤0.01% |
1,624
+56
| +4% | +$1.07K |
|
|
PHX
3625
DELISTED
PHX Minerals
PHX
| $40.6K | ﹤0.01% |
3,626
+1,093
| +43% | +$14.4K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2019 Portfolio in Review
As of Q4 2019, BNP Paribas Financial Markets held 4,613 positions worth $54.9B, down 2.5% from $56.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.1B in Q4 2019, closing 185 positions and reducing 1,420 holdings. Its most notable exit was Celgene Corp, an estimated $56.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.3% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares US Financials ETF worth $124M.
- BNP Paribas Financial Markets's largest Q4 2019 buy was iShares US Financials ETF: 1,800,000 shares worth $124M.
- BNP Paribas Financial Markets added most to Bristol-Myers Squibb in Q4 2019, an estimated $140M increase.
- BNP Paribas Financial Markets's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Celgene Corp in Q4 2019, selling an estimated $56.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $54.9B portfolio in Q4 2019.
- BNP Paribas Financial Markets opened 106 new positions and closed 185 in Q4 2019.
- BNP Paribas Financial Markets's portfolio value fell 2.5% quarter-over-quarter to $54.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.